Teladoc Health Inc
For the period ended Dec 31, 2023. Filed Feb 23, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 23, 2024
TDOC$8.98+2.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTAL DATA
| Page | |
|---|---|
| 1. Audited Consolidated Financial Statements of Teladoc Health, Inc. | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 42) | F-2 |
| Consolidated Balance Sheets | F-4 |
| Consolidated Statements of Operations and Other Comprehensive Loss | F-5 |
| Consolidated Statements of Stockholders’ Equity | F-6 |
| Consolidated Statements of Cash Flows | F-7 |
| Notes to Audited Consolidated Financial Statements | F-8 |
| 2. Supplemental Financial Data: | |
| The following supplemental financial data of the Registrant required to be included in Item 15(a)(2) on Form 10-K are listed below: | |
| Schedule II – Valuation and Qualifying Accounts | 74 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.